TrialPhase I/II/III Gene Transfer Clinical Trial of scAAV9.U1a.hSGSH
Trial details
- Registry ID
- NCT02716246
- Phase
- Phase 2, Phase 3
Drug research
UX111
Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.
Drug identity checked against registry records
Also recorded as ABO-102; rebisufligene etisparvovec; scAAV9.U1a.hSGSH
A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.
Included trials
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Phase I/II/III Gene Transfer Clinical Trial of scAAV9.U1a.hSGSHNCT02716246 | RARE | Phase 2, Phase 3 | Recruiting | 2029-03Estimated |
Regulatory dates and decisions
| No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed. |